[{"data":1,"prerenderedAt":148},["ShallowReactive",2],{"drug-simvastatin":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":68,"contraindications":113,"warnings":132,"renal":133,"monitoring":134,"interactions":135,"review":136,"examples":139},"simvastatin",1,{"fa":7,"en":8},"سیمواستاتین","Simvastatin","cardiovascular",{"fa":11,"en":12},"استاتین","Statin (HMG-CoA reductase inhibitor)",[14],{"name":15,"market":16},"Zocor","US",[18,19,7,20,11],"zocor","زوکور","statin",[22,36,44,52,60],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":31,"refs":32},"tab-5","tablet","oral","5 mg tablet",{"amount":28,"unit":29,"perUnit":24,"scored":30},5,"mg",false,[16],[33],{"source":34,"section":35},"fda-simvastatin","3",{"id":37,"form":24,"route":25,"label":38,"concentration":39,"markets":41,"refs":42},"tab-10","10 mg tablet",{"amount":40,"unit":29,"perUnit":24,"scored":30},10,[16],[43],{"source":34,"section":35},{"id":45,"form":24,"route":25,"label":46,"concentration":47,"markets":49,"refs":50},"tab-20","20 mg tablet",{"amount":48,"unit":29,"perUnit":24,"scored":30},20,[16],[51],{"source":34,"section":35},{"id":53,"form":24,"route":25,"label":54,"concentration":55,"markets":57,"refs":58},"tab-40","40 mg tablet",{"amount":56,"unit":29,"perUnit":24,"scored":30},40,[16],[59],{"source":34,"section":35},{"id":61,"form":24,"route":25,"label":62,"concentration":63,"markets":65,"refs":66},"tab-80","80 mg tablet",{"amount":64,"unit":29,"perUnit":24,"scored":30},80,[16],[67],{"source":34,"section":35},[69,99],{"id":70,"disease":71,"label":72,"population":75,"type":79,"unit":29,"dose":80,"refs":81,"limits":84,"notes":88},"adult","hyperlipidemia",{"fa":73,"en":74},"چربی خون — بزرگسال: ۲۰ تا ۴۰ mg عصر","Hyperlipidemia — adults: 20–40 mg in the evening",{"minAge":76},{"value":77,"unit":78},18,"year","fixed",{"perDose":48,"perDoseMax":56,"dosesPerDay":5},[82],{"source":34,"section":83},"2.2",{"maxPerDay":56,"refs":85},[86],{"source":34,"section":87},"2.1",[89],{"text":90,"refs":93},{"fa":91,"en":92},"حداکثر توصیه‌شده ۴۰ mg؛ ۸۰ mg فقط برای کسانی که ≥۱۲ ماه بدون مشکل عضلانی ۸۰ mg مصرف کرده‌اند. با آمیودارون، آملودیپین یا رانولازین حداکثر ۲۰ mg. نارسایی کلیه شدید: شروع ۵ mg.","Max recommended 40 mg; 80 mg only for patients on 80 mg ≥12 months without muscle toxicity. With amiodarone, amlodipine or ranolazine max 20 mg. Severe renal impairment: start 5 mg.",[94,95,97],{"source":34,"section":87},{"source":34,"section":96},"2.5",{"source":34,"section":98},"2.4",{"id":100,"disease":71,"label":101,"population":104,"type":79,"unit":29,"dose":107,"refs":108},"hefh",{"fa":102,"en":103},"هیپرکلسترولمی خانوادگی هتروزیگوت — ۱۰ سال به بالا: ۱۰ تا ۴۰ mg","Heterozygous FH — ≥10 y: 10–40 mg",{"minAge":105,"maxAge":106},{"value":40,"unit":78},{"value":77,"unit":78},{"perDose":40,"perDoseMax":56,"dosesPerDay":5},[109,111],{"source":34,"section":110},"2.3",{"source":34,"section":112},"8.4",[114,123],{"id":115,"severity":116,"text":117,"refs":120},"ci","block",{"fa":118,"en":119},"همراه مهارکننده‌های قوی CYP3A4 (آزول‌ها، ماکرولیدها، ضدویروس‌ها، نفازودون)، سیکلوسپورین، دانازول یا جم‌فیبروزیل (و سایر موارد بخش ۴).","With strong CYP3A4 inhibitors (azoles, macrolides, antivirals, nefazodone), cyclosporine, danazol or gemfibrozil (and other items in section 4).",[121],{"source":34,"section":122},"4",{"id":124,"severity":116,"rule":125,"text":127,"refs":130},"under-10",{"maxAge":126},{"value":40,"unit":78},{"fa":128,"en":129},"زیر ۱۰ سال ثابت نشده.","Not established under 10 years.",[131],{"source":34,"section":112},[],[],[],[],{"status":137,"reviewer":138,"date":138},"unverified",null,[140,144],{"regimen":70,"formulation":45,"input":141,"expect":143},{"ageYears":142,"weightKg":64},55,{"perDose":48,"upperPerDose":56},{"regimen":100,"formulation":37,"input":145,"expect":147},{"ageYears":146,"weightKg":56},12,{"perDose":40},1792078540556]